Calcimedica, INC DEF 14A proxy statements

CalciMedica, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for August 19, 2026, to vote on several critical proposals including a reverse stock split, equity plan amendments, and warrant issuances.

CalciMedica, Inc. has informed stockholders of a change in its independent registered public accounting firm from Moss Adams LLP to Baker Tilly US, LLP, effective June 3, 2025, due to a merger between the two accounting firms.

CalciMedica, Inc. will hold its annual stockholders meeting on June 24, 2025, to elect directors, ratify the appointment of its accounting firm, and approve an amendment to its equity incentive plan.

CalciMedica is asking stockholders to approve an amendment to its 2023 Equity Incentive Plan to increase the number of shares available for issuance by 600,000.

CalciMedica, Inc. will hold its annual meeting on August 27, 2024, to vote on the election of directors, ratification of auditors, and an amendment to the equity incentive plan.

CalciMedica is holding its annual stockholder meeting on August 27, 2024, to vote on the election of directors, ratification of the accounting firm, and an amendment to the equity incentive plan.